Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02979496 · ClinicalTrials.gov registry record · NA
Citrus Beverages and Gastrointestinal Function
A NA study, sponsored by University of Florida.
- Completed
- Registry status
- NA
- Development phase
- 330
- Enrollment target
NCT02979496: Completed NA study, sponsored by University of Florida.
NCT02979496 is a NA study that has completed, run by University of Florida. The registered enrollment target is 330 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (76% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02979496, a NA study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 330 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effect of daily intake of orange pomace on gastrointestinal function as measured by stool frequency. Additional outcomes will include aspects of digestive health, diet quality, and fasting blood glucose and lipid concentrations. Possible explanations for the mechanism of the pomace will be explored in microbial ecology analyses.
Primary Outcome
The average number of stools per week compared between intervention groups.
Interventions
- DIETARY_SUPPLEMENT 0 g pomace (control)
- DIETARY_SUPPLEMENT 90 g pomace
- DIETARY_SUPPLEMENT 180 g pomace
- DIETARY_SUPPLEMENT Flavored water (control)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 330 participants |
| Start Date | 2017-02-13 |
| Est. Completion | 2017-04-29 |
| Phase | NA |
What the finished NCT02979496 record still lists
NCT02979496 is an interventional study that assigns participants to a tested intervention. The registered 330 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (76% lower).
The record links to 0 conditions, and to 4 interventions - of which 0 g pomace (control) is the first listed.
NCT02979496 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02979496 about?
NCT02979496 is a clinical study titled "Citrus Beverages and Gastrointestinal Function". The purpose of this study is to evaluate the effect of daily intake of orange pomace on gastrointestinal function as measured by stool frequency. Additional outcomes will include aspects of digestive health, diet quality, and fasting blood glucose and lipid concentrations. Possible explanations for ...
What is the current status of trial NCT02979496?
This trial is currently completed. It is a NA study. The enrollment target is 330 participants. The study started on 2017-02-13. Estimated completion is 2017-04-29.
What interventions are being tested in trial NCT02979496?
The interventions under investigation include: 0 g pomace (control) (DIETARY_SUPPLEMENT), 90 g pomace (DIETARY_SUPPLEMENT), 180 g pomace (DIETARY_SUPPLEMENT), Flavored water (control) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02979496?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02979496's enrollment target sits among peer trials
330 307th of 2000 higher than 1,693 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00359684 · 330 participants
Use of Cysteamine in the Treatment of Cystinosis
- NCT03817502 · 330 participants · Phase 3
Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With Schizophrenia
- NCT03922724 · 330 participants · Phase 2
Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma
- NCT03932773 · 330 participants · NA
Multi-site Confirmatory Efficacy Treatment Trial of Combat-related PTSD
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI